Biotech

All Articles

Galapagos stops briefly CAR-T tissue therapy litigation over Parkinsonism instance

.Galapagos has actually paused registration in a test of a BCMA-directed CAR-T cell treatment, pushi...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After greater than 30 years, genetics therapy trendsetter James Wilson M.D., Ph.D., is actually lea...

3 biotechs attempt to trump the summertime warm by losing team

.As biotechs try to transform a fresh web page in August, at the very least three business have actu...

venBio elevates $528M for fifth lifestyle scientific researches VC fund

.Veteran financial backing firm venBio has actually lifted an additional half a billion dollars to a...

Otsuka pays out $800M for Jnana as well as its own clinical-stage PKU medicine

.Otsuka Pharmaceutical has picked up Boston-based Jnana Therapeutics for $800 thousand so the Orient...

FibroGen gives up 75% of US workers as property flunks 2 even more tests

.FibroGen is significantly reorganizing its own organization, laying off 75% of its united state per...

Tracon relax weeks after injectable PD-L1 inhibitor fail

.Tracon Pharmaceuticals has actually made a decision to relax procedures weeks after an injectable i...

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on neglected epilepsy medicine, promotes FDA operate

.Our team currently recognize that Takeda is wanting to locate a road to the FDA for epilepsy medica...

VBI Injections files for personal bankruptcy, looks for resource sale

.Immunology biotech VBI Vaccinations is drifting alarmingly near to the point of no return, with pla...